Opthea Ltd: Opthea's Wet AMD Program to be Featured at FLORetina 2024
Opthea Ltd: Opthea Participate in Citi 2024 Global Healthcare Conference
Opthea Ltd: Opthea's Wet AMD Program Featured at Ophthalmology Events
Opthea Ltd: Update Opthea Participates in November Investor Conferences
Opthea Ltd: Opthea to Participate in November Investor Conferences
Opthea Ltd: Opthea Wet AMD Program to be Presented at Innovate Retina
Opthea Ltd: Opthea Appoints Chief Medical and Chief Financial Officer
Opthea Ltd: Opthea to participate in UBS Virtual Ophthalmology Day 2024
Opthea Ltd: Opthea Joins the S&P/ASX 300 Index
Opthea Ltd: Opthea Announces Completion of Drug Substance Campaign
Opthea Ltd: Opthea Presents at the 24th EURETINA Congress
Opthea Ltd: Opthea Announces Executive Leadership Changes & Senior Hires
Opthea Ltd: Opthea presents at H.C.Wainwright 26th Investment Conference
Opthea Ltd: Opthea 2024 Corporate Governance Statement
Opthea Ltd: Opthea to Participate in H.C Wainwright Virtual Conference
Opthea Ltd: Updated Quarterly Report and Cashflow
Opthea Ltd: Quarterly Activities/Appendix 4C Cash Flow Report
Opthea Ltd: Opthea Welcomes Retina Leaders to its Medical Advisory Board
Opthea Ltd: Security Class Reinstatement to Quotation- OPTOB
Opthea Ltd: OPTOB Top Holders
No Data
No Data